Washington Trust Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22
Closed -$4.36K 726
2023
Q1
$4.36K Sell
22
-16
-42% -$3.29K ﹤0.01% 630
2022
Q4
$7.77K Sell
38
-167
-81% -$32.6K ﹤0.01% 529
2022
Q3
$36K Buy
205
+79
+63% +$16.2K ﹤0.01% 433
2022
Q2
$25K Buy
126
+5
+4% +$1.07K ﹤0.01% 501
2022
Q1
$27K Buy
121
+94
+348% +$22.1K ﹤0.01% 548
2021
Q4
$7K Buy
+27
New +$6.68K ﹤0.01% 791

Other funds holding LH

Washington Trust Advisors's LH Position: Q2 2023 in Review

Washington Trust Advisors sold out of Labcorp (LH) in Q2 2023, closing a stake of 22 shares — an estimated $4.36K sold.

Washington Trust Advisors first reported a position in LH in Q4 2021 and held it in 6 quarters. The position peaked at $36K in Q3 2022. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

  • Washington Trust Advisors reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
  • Washington Trust Advisors sold 22 Labcorp shares in Q2 2023, an estimated $4.36K.
  • Washington Trust Advisors first reported a position in Labcorp in Q4 2021 and held it in 6 quarters.
  • Washington Trust Advisors's Labcorp position peaked at $36K in Q3 2022.
  • 932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Washington Trust Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.